Gene Panel Early-Onset Juvenile Parkinsonism Test

This test:

• Measures genetic mutations in ATP13A2, DNAJC6, FBX07, LRRK2, PARK7, PINK1, PLA2G6, PRKN, RAB39B, SLC6A3, SNCA, SYNJ1, VAC14, VPS13C
• Identifies specific gene abnormalities linked to early-onset Parkinsonism
• Helps understand the genetic basis of Parkinson's disease development

• To detect genetic mutations causing early-onset juvenile Parkinsonism
• To guide treatment decisions for Parkinson's disease
• To help predict disease progression and response to therapies

The Gene Panel Early-Onset Juvenile Parkinsonism Test is recommended for:

• Patients showing symptoms like tremors, muscle stiffness, and balance issues at a younger age
• Patients with a family history of neurological disorders
• Individuals needing confirmation of an early-onset Parkinsonism diagnosis

Abnormal results may suggest a predisposition to early-onset Parkinsonism. Abnormalities in specific genes can help determine treatment strategies

• Blood sample to be drawn by a healthcare professional
• Sample sent to a laboratory for genetic analysis
• Results to be shared with your doctor for interpretation

• Follow any instructions provided by your doctor
• Avoid any specific medications before the test
• Provide detailed information about your medical history

• MRI Brain Scan: To assess neurological changes
• Dopamine Transporter Scan: To evaluate dopamine levels in the brain
• Blood Tests: To check for other associated conditions

Genetic Panel for Early-Onset Juvenile Parkinsonism or Molecular Pathology Test for Early-Onset Juvenile Parkinson's Disease

Juvenile Parkinsonism refers to a rare form of Parkinson's disease that usually affects individuals under the age of 21. It involves an early onset of symptoms related to movement disorders due to genetic mutations affecting specific proteins in the brain